Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice.
Lim S, Shin S, Sung Y, Lee HE, Kim KH, Song JY, Lee GH, Aziz H, Lukianenko N, Kang DM, Boesen N, Jeong H, Abdildinova A, Lee J, Yu BY, Lim SM, Lee JS, Ryu H, Pae AN, Kim YK.
Lim S, et al. Among authors: lee js, lee j, lee he, lee gh.
Exp Mol Med. 2023 Mar;55(3):612-627. doi: 10.1038/s12276-023-00959-5. Epub 2023 Mar 13.
Exp Mol Med. 2023.
PMID: 36914856
Free PMC article.